Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S280000
Reexamination Certificate
active
07981903
ABSTRACT:
Novel pyrrolopyrimidines as shown in formula (I):and pharmaceutically acceptable derivatives thereof. The compounds are useful in the inhibition of IGF-1R.
REFERENCES:
patent: 2005016894 (2005-02-01), None
patent: 2006017443 (2006-02-01), None
Chamberlain Stanley Dawes
Deanda, Jr. Felix
Gerding Roseanne
Hasegawa Masaichi
Kuntz Kevin
GlaxoSmithKline LLC
Murray Jeffrey H
Wilson James O
Young J. Scott
LandOfFree
2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino]... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino]..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino]... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2693758